Trials / Completed
CompletedNCT03665402
A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status
Clinical Trial to Investigate the Appropriate Dose of Isoniazid According to NAT2 Polymorphism Status in Korean Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to investigate the appropriate dose of isoniazid according to NAT2 polymorphism status in Korean subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isoniazid | One of the first line anti-tubercolosis drug |
Timeline
- Start date
- 2018-05-13
- Primary completion
- 2018-12-31
- Completion
- 2019-03-31
- First posted
- 2018-09-11
- Last updated
- 2020-02-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03665402. Inclusion in this directory is not an endorsement.